000 01818nam  2200385zi 4500
0019.861981
003CaOODSP
00520221107160909
006m     o  d f      
007cr |||||||||||
008180914s20182018onc     o    f00| 0 eng d
020 |a9780660278421
040 |aCaOODSP|beng|erda|cCaOODSP
043 |an-cn---
0861 |aH14-268/2018E-PDF
24500|aTesting of relative risk statements for vaping products : |bfinal report / |cprepared by: Corporate Research Associates Inc.
264 1|a[Ottawa] : |bHealth Canada = Santé Canada, |c2018.
264 4|c©2018
300 |a1 online resource (2 volumes)
336 |atext|btxt|2rdacontent
337 |acomputer|bc|2rdamedia
338 |aonline resource|bcr|2rdacarrier
500 |aIssued also in French under title: Évaluation d’énoncés sur les risques relatifs aux produits de vapotage.
500 |aIssued also in HTML.
500 |aTitle from cover.
500 |a"Prepared for Health Canada."
69207|2gccst|aSmoking
7101 |aCanada. |bHealth Canada.
7102 |aCorporate Research Associates.
77508|tÉvaluation d’énoncés sur les risques relatifs aux produits de vapotage : |w(CaOODSP)9.861985
85640|qPDF|s777 KB|uhttps://publications.gc.ca/collections/collection_2019/sc-hc/H14-268-2018-eng.pdf|zFinal report
85640|qPDF|s185 KB|uhttps://publications.gc.ca/collections/collection_2019/sc-hc/H14-268-2018-1-eng.pdf|zExecutive summary
8564 |qHTML|sN/A|uhttps://epe.lac-bac.gc.ca/100/200/301/pwgsc-tpsgc/por-ef/health/2019/014-18-e/Vaping_RRS_report-rapport-eng.html|zFinal report
8564 |qHTML|sN/A|uhttps://epe.lac-bac.gc.ca/100/200/301/pwgsc-tpsgc/por-ef/health/2019/014-18-e/summary/Vaping_RRS_summary-sommaire-eng.html|zExecutive summary